Correlation Between Iovance Biotherapeutics and TG Therapeutics
Can any of the company-specific risk be diversified away by investing in both Iovance Biotherapeutics and TG Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Iovance Biotherapeutics and TG Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Iovance Biotherapeutics and TG Therapeutics, you can compare the effects of market volatilities on Iovance Biotherapeutics and TG Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Iovance Biotherapeutics with a short position of TG Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Iovance Biotherapeutics and TG Therapeutics.
Diversification Opportunities for Iovance Biotherapeutics and TG Therapeutics
-0.37 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Iovance and TGTX is -0.37. Overlapping area represents the amount of risk that can be diversified away by holding Iovance Biotherapeutics and TG Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on TG Therapeutics and Iovance Biotherapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Iovance Biotherapeutics are associated (or correlated) with TG Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of TG Therapeutics has no effect on the direction of Iovance Biotherapeutics i.e., Iovance Biotherapeutics and TG Therapeutics go up and down completely randomly.
Pair Corralation between Iovance Biotherapeutics and TG Therapeutics
Given the investment horizon of 90 days Iovance Biotherapeutics is expected to under-perform the TG Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Iovance Biotherapeutics is 1.05 times less risky than TG Therapeutics. The stock trades about -0.09 of its potential returns per unit of risk. The TG Therapeutics is currently generating about 0.27 of returns per unit of risk over similar time horizon. If you would invest 2,571 in TG Therapeutics on August 30, 2024 and sell it today you would earn a total of 929.00 from holding TG Therapeutics or generate 36.13% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Insignificant |
Accuracy | 95.65% |
Values | Daily Returns |
Iovance Biotherapeutics vs. TG Therapeutics
Performance |
Timeline |
Iovance Biotherapeutics |
TG Therapeutics |
Iovance Biotherapeutics and TG Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Iovance Biotherapeutics and TG Therapeutics
The main advantage of trading using opposite Iovance Biotherapeutics and TG Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Iovance Biotherapeutics position performs unexpectedly, TG Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in TG Therapeutics will offset losses from the drop in TG Therapeutics' long position.Iovance Biotherapeutics vs. PTC Therapeutics | Iovance Biotherapeutics vs. Krystal Biotech | Iovance Biotherapeutics vs. Sarepta Therapeutics | Iovance Biotherapeutics vs. Madrigal Pharmaceuticals |
TG Therapeutics vs. Madrigal Pharmaceuticals | TG Therapeutics vs. Terns Pharmaceuticals | TG Therapeutics vs. Hepion Pharmaceuticals | TG Therapeutics vs. Exelixis |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.
Other Complementary Tools
My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon |